Annotated Medicine and Device Lists

Amoxicillin + clavulanic acid

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.2.1. Access group antibiotics Others observations:
FIRST CHOICE − Community acquired pneumonia (severe) [c] − Complicated intraabdominal infections (mild to moderate) − Exacerbations of COPD − Hospital acquired pneumonia − Low-risk febrile neutropenia − Lower urinary tract infections − Sinusitis − Skin and soft tissue infections SECOND CHOICE − Bone and joint infections − Community-acquired pneumonia (mild to moderate) − Community acquired pneumonia (severe) − Otitis media − Surgical prophylaxis [c]: only for children

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.2.5. Antituberculosis medicines This medicine requires a children care specialist.
Others observations:
Medicines for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control. For use only in combination with meropenem or imipenem+cilastatin.
Peru 6.2.1.1 Penicillins No observations
Venezuela (incomplete) List of Generic Medications - Venezuela No observations
WHO Model List of Essential Medicines (2021) 6.2.1. Access group antibiotics Others observations:
FIRST CHOICE − Community acquired pneumonia (severe) [c] − Complicated intraabdominal infections (mild to moderate) − Exacerbations of COPD − Hospital acquired pneumonia − Low-risk febrile neutropenia − Lower urinary tract infections − Sinusitis − Skin and soft tissue infections SECOND CHOICE − Bone and joint infections − Community-acquired pneumonia (mild to moderate) − Community acquired pneumonia (severe) − Otitis media − Surgical prophylaxis [c]: only for children

This medicine is present in:

List Section Observation
Chile Essential and Prioritized Medications No observations
Venezuela (incomplete) List of Generic Medications - Venezuela No observations

This medicine is present in:

List Section Observation
Chile Essential and Prioritized Medications No observations
WHO Model List of Essential Medicines (2021) 6.2.1. Access group antibiotics Others observations:
FIRST CHOICE − Community acquired pneumonia (severe) [c] − Complicated intraabdominal infections (mild to moderate) − Exacerbations of COPD − Hospital acquired pneumonia − Low-risk febrile neutropenia − Lower urinary tract infections − Sinusitis − Skin and soft tissue infections SECOND CHOICE − Bone and joint infections − Community-acquired pneumonia (mild to moderate) − Community acquired pneumonia (severe) − Otitis media − Surgical prophylaxis [c]: only for children

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.2.1. Access group antibiotics Others observations:
FIRST CHOICE − Community acquired pneumonia (severe) [c] − Complicated intraabdominal infections (mild to moderate) − Exacerbations of COPD − Hospital acquired pneumonia − Low-risk febrile neutropenia − Lower urinary tract infections − Sinusitis − Skin and soft tissue infections SECOND CHOICE − Bone and joint infections − Community-acquired pneumonia (mild to moderate) − Community acquired pneumonia (severe) − Otitis media − Surgical prophylaxis [c]: only for children

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.2.5. Antituberculosis medicines Others observations:
Medicines for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control. For use only in combination with meropenem or imipenem+cilastatin.
PAHO Strategic Fund Medicine List 2.1. Antibacterial No observations
WHO Model List of Essential Medicines (2021) 6.2.1. Access group antibiotics Others observations:
FIRST CHOICE − Community acquired pneumonia (severe) [c] − Complicated intraabdominal infections (mild to moderate) − Exacerbations of COPD − Hospital acquired pneumonia − Low-risk febrile neutropenia − Lower urinary tract infections − Sinusitis − Skin and soft tissue infections SECOND CHOICE − Bone and joint infections − Community-acquired pneumonia (mild to moderate) − Community acquired pneumonia (severe) − Otitis media − Surgical prophylaxis [c]: only for children

This medicine is present in:

List Section Observation
Peru 6.2.1.1 Penicillins No observations
Chile Essential and Prioritized Medications No observations

This medicine is present in:

List Section Observation
Chile Essential and Prioritized Medications No observations
WHO Model List of Essential Medicines (2021) 6.2.1. Access group antibiotics Others observations:
FIRST CHOICE − Community acquired pneumonia (severe) [c] − Complicated intraabdominal infections (mild to moderate) − Exacerbations of COPD − Hospital acquired pneumonia − Low-risk febrile neutropenia − Lower urinary tract infections − Sinusitis − Skin and soft tissue infections SECOND CHOICE − Bone and joint infections − Community-acquired pneumonia (mild to moderate) − Community acquired pneumonia (severe) − Otitis media − Surgical prophylaxis [c]: only for children

Information Resources: Amoxicillin + clavulanic acid

No information available